CALTON & ASSOCIATES, INC. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 195 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.

Quarter-by-quarter ownership
CALTON & ASSOCIATES, INC. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$409,000
+87.6%
6,016
-4.8%
0.23%
+260.0%
Q1 2022$218,000
-28.3%
6,321
-39.3%
0.06%
-19.8%
Q4 2021$304,000
-5.9%
10,418
-17.9%
0.08%
+14.1%
Q3 2021$323,000
+47.5%
12,696
+108.6%
0.07%
+69.0%
Q2 2021$219,000
-13.1%
6,086
-1.6%
0.04%
-14.3%
Q1 2021$252,000
-7.4%
6,188
-1.6%
0.05%0.0%
Q4 2020$272,000
-13.4%
6,288
+10.4%
0.05%
-23.4%
Q3 2020$314,000
-8.5%
5,695
+4.9%
0.06%
-14.7%
Q2 2020$343,000
+23.4%
5,430
-0.1%
0.08%
+8.7%
Q1 2020$278,000
+16.3%
5,435
+80.8%
0.07%
+43.8%
Q4 2019$239,0003,0060.05%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2022
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$680.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders